why choose us

First received: March 08, 2024

Clinical Trial: A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: Multicentre, Randomised, Double-blind, Placebo-controlled, 48-week, Phase III Trial to Evaluate the Efficacy and Safety of Survodutide Administered Subcutaneously in Participants With Overweight or Ob

Brief Summary: This study is open to adults who are at least 18 years old and havepresumed or confirmed NASH together with overweight or obesity anda body mass index (BMI) of 30 kg/m² or more, ora BMI of 27 kg/m² and at least one weight-related health problem.People with a history of other chronic liver diseases cannot take part in this study.The purpose of this study is to find out whether a medicine called survodutide helps people living with obesity or overweight and a confirmed or presumed liver disease called…

Read more